Aquila joins International Collaboration for the Malaria Vaccine Initiative
August 12, 2015— Edmonton, Alberta — Aquila Diagnostics Inc. today announced its participation in a project with the PATH Malaria Vaccine Initiative to improve testing for malaria infectiousness.
Working closely with Dr. Stephanie Yanow of the University of Alberta and researchers at Radboud University Medical Centre in Holland and Harvard University, Aquila is providing its AccutasTM portable diagnostic system to rapidly detect genetic markers in blood samples in the field to help curb the transmission of malaria.